Respiratory Flashcards
Acute asthma (asthma attack) moderate details
- peak flow > 50%
- can complete full sentences
- SpO2 > >92%
- RR > > 30 (5+ years)
- RR > > 40 (1-5 years)
Acute asthma severe details
- peak flow 33-50%
- cant complete full sentences
- RR > > 25 (adult)
- RR > 30 (5+ years)
- RR > 40 (1-5 years)
- HR > 125 bpm (5+ years)
- HR > 140 bpm (1-5 years)
Acute asthma life - threatening details
- peak flow < 33%
- SpO2 < 92%
- cyanosis
- silent chest
- altered consciousness
- hypotension
- exhaustion
Acute asthma moderate adults management
- home or primary care - hospital if inadequate response
- tx = high dose SABA (10 puffs) via PMI and spacer
Acute asthma severe/life threatening adults management
- hospital immediately
- tx = high dose SABA via oxygen driven nebuliser +/- nebulised ipratopium
- life threatening with poor response to initial therapy = IV aminophyllin
- all patient = oral prednisone (40mg 5 days) - if inappropriate = IV hydrocortisone or IM methylpred
- Hypoxaemic = supplementary O2 (maintain between 94-98%)
Acute asthma children 2 years and older severe/life threatening management
- hospital ASAP (O2 in life threatening of SpO2 <94%)
- 1st line = SABA via oxygen driven nebuliser
- 3 days oral pred
- poor initial response to B2 agonist = add nebulised ipratropium
- poor response to 1st line = IV magnesium sulfate
Acute asthma children 2 years and older mild-moderate management
- 1st line = SABA via PMI and spacer - medical attention if not controlled after 10 puffs
- 3 days oral pred
- poor initial response to B2 agonist = add nebulised ipratropium
- poor response to 1st line tx = IV magnesium sulfate
Acute asthma management under 2 years old
- all under 2s admitted to hospital
- mod-severe = immediate oxygen and trial SABA
- if needed combine nebulised ipratropium bromide
Chronic asthma lifestyle advice
weight loss, smoking cessation, breathing exercise programmes
Chronic asthma treatment adults
- SABA (salbutamol)
- SABA + low dose ICS (beclamethasone 200mcg BD)
- SABA + ICS + LTRA (montelukast) (NICE)
3.1 SABA + ICS + LABA (fixed or MART e.g. fostair/symbicort) (BTS/SIGN)
4. LABA with/w/o LTRA - can convert LABA and mod ICS to MART
5. increase ICS to high strength OR specialist = theophylline, tiotropium (12+), coral corticosteroids, monoclonal antibodies
Chronic asthma treatment children over 5
- SABA
- SABA + low dose ICS (100mcg BD)
- SABA + ICS + LTRA (NICE)/LABA (BTS/SIGN) - if 12 years plus
- Replace LTRA with LABA - MART if still no change
- increase ICS strength OR specialist = theophylline, tiotropium (12+), oral corticosteroids, monoclonal antibodies
For chronic asthma treatment when should you move to the next step of treatment
if using SABA 3x week, symptoms 3x week, night awakening 1x week, > 1 inhaler per month
Chronic asthma treatment children under 5
- SABA
- SABA + low dose ICS - 8 wk trial before continuing
- if ICS not tolerated= LTRA - SABA + ICS + LTRA
- stop LTRA and refer to specialist
Chronic asthma treatment dropping down criteria
- when asthma controlled for at least 3 months
- regularly r/v patients when decreasing tx
- maintain lowest effective use of ICS - consider reducing every 3 months by 25-50%
What is complete control of asthma
- no day time symptoms
- no night-time awakening due to asthma
- no asthma attacks
- no need for rescue medication
- no limitations on activity including exercise
- normal lung function (FEV and/or PEF > 80% predicted or best)
- minimal side effects from tx
COPD non-asthmatic features treatment
- SABA or SAMA (SABA continued throughout)
- LAMA + LABA - stop SAMA
- LAMA + LABA + ICS - if 1 sev exacerbation or 2+ mod exacerbation per year - if no change after 3 months = back to LAMA + LABA
- theophylline, oxygen therapy, mucolytics
COPD asthmatic features treatment
- SABA or SAMA (SABA continued throughout)
- LABA + ICS - stop SAMA
- LAMA + LABA + ICS - if 1 sev exacerbation or 2+ mod exacerbation per year
- theophylline, oxygen therapy, mucolytics
COPD exacerbation prophylactic treatment
- azithromycin 250mg 3x week
- offer pneumococcal and influenza vaccine
COPD condition description
- progressive and not fully reversible
- persistent respiratory symptoms
- airflow limitation due to a combination of obstructive bronchiolitis and emphysema
- symptoms = dyspnoea, wheeze, chronic cough, regular sputum production
COPD risk factors
- smoking
- pollution & occupational exposures
- genetic factors
COPD rescue pack information
- exacerbation in last year = give rescue pack:
- Oral corticosteroid (usually pred) + Oral Abx (usually amox) - can be amox, doxy or clarithro
- avoid clarithro if pt on prophylactic azithro
Non drug treatment of COPD exacerbation
positive expiratory pressure helps sputum clearance
COPD exacerbation drug treatment
- SAMA/SABA - hold LAMA if SAMA given (increased muscarinic side effects)
- hospital = short course pred (30mg 5 days) and other therapies
- community = short course pred (30mg 5 days) if significant breathlessness
- aminophylline added if inadequate response to nebulised bronchodilators
- oxygen if needed to keep O2 saturation of arterial blood levels in range
Name SABAs
- salbutamol, terbutaline (4 hours)
- 1-2 QDS, 8 puffs max daily, 10 max in acute asthma attack
Name LABAs
- salmeterol, formeterol, vilanterol (12 hours)
SABA/LABA cautions
- diabetes - DKA after IV administration
- can increase risk of arrhythmias
- causes hypokalaemia - increase risk of QT prolongation
- risk of digoxin toxicity due to hypokalaemia
SABA/LABA side effects
- fine tremor
- palpitations
- headache
- seizure
- anxiety
- QT interval prolongation with corticosteroids, diuretics, theophylline